ENFN logo

Enfusion (ENFN) Company Overview

Profile

Full Name:

Enfusion, Inc.

Sector:

Technology

Country:

United States

IPO:

October 21, 2021

Indexes:

Not included

Description:

Enfusion is a financial technology company that provides cloud-based software solutions for investment management. It helps asset managers streamline operations, improve efficiency, and enhance decision-making through tools for portfolio management, risk analysis, and reporting. Their platform supports various investment strategies and offers real-time data access.

Key Details

Price

$11.13

Annual Revenue

$174.53 M(+16.09% YoY)

Annual EPS

$0.07(+170.00% YoY)

PE Ratio

278.13

Beta

0.73

Events Calendar

Earnings

Next earnings date:

Mar 12, 2025

Recent quarterly earnings:

Nov 4, 2024

Recent annual earnings:

Mar 12, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Jan 13, 25 William Blair
Market Perform
Dec 23, 24 Piper Sandler
Neutral
Dec 18, 24 Stifel
Buy
Mar 13, 24 B of A Securities
Underperform
Feb 28, 24 Goldman Sachs
Sell
Jan 30, 24 JP Morgan
Underweight
Dec 20, 23 Piper Sandler
Neutral
Nov 7, 23 UBS
Neutral
Aug 9, 23 Morgan Stanley
Overweight
Aug 9, 23 Goldman Sachs
Neutral

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Enfusion, Inc. (ENFN) and Encourages Investors to Learn More About the Investigation
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Enfusion, Inc. (ENFN) and Encourages Investors to Learn More About the Investigation
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Enfusion, Inc. (ENFN) and Encourages Investors to Learn More About the Investigation
ENFN
accessnewswire.comFebruary 5, 2025

NEW YORK CITY, NY / ACCESS Newswire / February 5, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Enfusion, Inc. ("Enfusion") (NYSE:ENFN) and Clearwater Analytics. Investors who purchased Enfusion and continue to hold to the present are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ENFN.

Enfusion, Inc. (ENFN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation
Enfusion, Inc. (ENFN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation
Enfusion, Inc. (ENFN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation
ENFN
accessnewswire.comFebruary 2, 2025

NEW YORK CITY, NY / ACCESS Newswire / February 2, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Enfusion, Inc. ("Enfusion") (NYSE:ENFN) and Clearwater Analytics. Investors who purchased Enfusion and continue to hold to the present are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ENFN.

Enfusion, Inc. Is Being Investigated For Securities Law Violations And Affected Shareholders Are Urged To Contact The Schall Law Firm
Enfusion, Inc. Is Being Investigated For Securities Law Violations And Affected Shareholders Are Urged To Contact The Schall Law Firm
Enfusion, Inc. Is Being Investigated For Securities Law Violations And Affected Shareholders Are Urged To Contact The Schall Law Firm
ENFN
accessnewswire.comJanuary 29, 2025

LOS ANGELES, CA / ACCESS Newswire / January 29, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Enfusion, Inc. ("Enfusion" or "the Company") (NYSE:ENFN) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the Enfusion board breached its fiduciary duties to shareholders.

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Enfusion, Inc. (ENFN) And Encourages Stockholders to Reach Out
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Enfusion, Inc. (ENFN) And Encourages Stockholders to Reach Out
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Enfusion, Inc. (ENFN) And Encourages Stockholders to Reach Out
ENFN
accessnewswire.comJanuary 29, 2025

NEW YORK CITY, NY / ACCESS Newswire / January 29, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Enfusion, Inc. ("Enfusion") (NYSE:ENFN) and Clearwater Analytics. Investors who purchased Enfusion and continue to hold to the present are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ENFN.

Enfusion, Inc. Is Being Investigated For Securities Law Violations And Affected Shareholders Are Urged To Contact The Schall Law Firm
Enfusion, Inc. Is Being Investigated For Securities Law Violations And Affected Shareholders Are Urged To Contact The Schall Law Firm
Enfusion, Inc. Is Being Investigated For Securities Law Violations And Affected Shareholders Are Urged To Contact The Schall Law Firm
ENFN
accessnewswire.comJanuary 27, 2025

LOS ANGELES, CA / ACCESS Newswire / January 27, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Enfusion, Inc. ("Enfusion" or "the Company") (NYSE:ENFN) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the Enfusion board breached its fiduciary duties to shareholders.

The Schall Law Firm Invites Investors With Losses To Join An Inquiry Into Enfusion, Inc. For Securities Fraud
The Schall Law Firm Invites Investors With Losses To Join An Inquiry Into Enfusion, Inc. For Securities Fraud
The Schall Law Firm Invites Investors With Losses To Join An Inquiry Into Enfusion, Inc. For Securities Fraud
ENFN
accessnewswire.comJanuary 26, 2025

LOS ANGELES, CA / ACCESS Newswire / January 26, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Enfusion, Inc. ("Enfusion" or "the Company") (NYSE:ENFN) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the Enfusion board breached its fiduciary duties to shareholders.

Bronstein, Gewirtz & Grossman, LLC Is Investigating Enfusion, Inc. (ENFN) And Encourages Stockholders to Connect
Bronstein, Gewirtz & Grossman, LLC Is Investigating Enfusion, Inc. (ENFN) And Encourages Stockholders to Connect
Bronstein, Gewirtz & Grossman, LLC Is Investigating Enfusion, Inc. (ENFN) And Encourages Stockholders to Connect
ENFN
accessnewswire.comJanuary 26, 2025

NEW YORK CITY, NY / ACCESS Newswire / January 26, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Enfusion, Inc. ("Enfusion") (NYSE:ENFN) and Clearwater Analytics. Investors who purchased Enfusion and continue to hold to the present are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ENFN.

Enfusion, Inc. Is Being Investigated For Securities Law Violations And Affected Shareholders Are Urged To Contact The Schall Law Firm
Enfusion, Inc. Is Being Investigated For Securities Law Violations And Affected Shareholders Are Urged To Contact The Schall Law Firm
Enfusion, Inc. Is Being Investigated For Securities Law Violations And Affected Shareholders Are Urged To Contact The Schall Law Firm
ENFN
accessnewswire.comJanuary 25, 2025

LOS ANGELES, CA / ACCESS Newswire / January 25, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Enfusion, Inc. ("Enfusion" or "the Company") (NYSE:ENFN) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the Enfusion board breached its fiduciary duties to shareholders.

The Schall Law Firm Invites Investors With Losses To Join An Inquiry Into Enfusion, Inc. For Securities Fraud
The Schall Law Firm Invites Investors With Losses To Join An Inquiry Into Enfusion, Inc. For Securities Fraud
The Schall Law Firm Invites Investors With Losses To Join An Inquiry Into Enfusion, Inc. For Securities Fraud
ENFN
accessnewswire.comJanuary 24, 2025

LOS ANGELES, CA / ACCESS Newswire / January 24, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Enfusion, Inc. ("Enfusion" or "the Company") (NYSE:ENFN) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the Enfusion board breached its fiduciary duties to shareholders.

Enfusion, Inc. Is Being Investigated For Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm
Enfusion, Inc. Is Being Investigated For Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm
Enfusion, Inc. Is Being Investigated For Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm
ENFN
accessnewswire.comJanuary 23, 2025

LOS ANGELES, CA / ACCESS Newswire / January 23, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Enfusion, Inc. ("Enfusion" or "the Company") (NYSE:ENFN) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the Enfusion board breached its fiduciary duties to shareholders.

FAQ

  • What is the ticker symbol for Enfusion?
  • Does Enfusion pay dividends?
  • What sector is Enfusion in?
  • What industry is Enfusion in?
  • What country is Enfusion based in?
  • When did Enfusion go public?
  • Is Enfusion in the S&P 500?
  • Is Enfusion in the NASDAQ 100?
  • Is Enfusion in the Dow Jones?
  • When was Enfusion's last earnings report?
  • When does Enfusion report earnings?
  • Should I buy Enfusion stock now?

What is the ticker symbol for Enfusion?

The ticker symbol for Enfusion is NYSE:ENFN

Does Enfusion pay dividends?

No, Enfusion does not pay dividends

What sector is Enfusion in?

Enfusion is in the Technology sector

What industry is Enfusion in?

Enfusion is in the Software Application industry

What country is Enfusion based in?

Enfusion is headquartered in United States

When did Enfusion go public?

Enfusion's initial public offering (IPO) was on October 21, 2021

Is Enfusion in the S&P 500?

No, Enfusion is not included in the S&P 500 index

Is Enfusion in the NASDAQ 100?

No, Enfusion is not included in the NASDAQ 100 index

Is Enfusion in the Dow Jones?

No, Enfusion is not included in the Dow Jones index

When was Enfusion's last earnings report?

Enfusion's most recent earnings report was on Nov 4, 2024

When does Enfusion report earnings?

The next expected earnings date for Enfusion is Mar 12, 2025

Should I buy Enfusion stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions